The selection of indicators from initial blood routine test results to improve the accuracy of early prediction of COVID-19 severity

por Luo, Jiaqing, Zhou, Lingyun, Feng, Yunyu, Li, Bo, Guo, Shujin
Publicado 2021

MEK Inhibitor Augments Antitumor Activity of B7-H3-Redirected Bispecific Antibody

por Li, Hongjian, Huang, Cheng, Zhang, Zongliang, Feng, Yunyu, Wang, Zeng, Tang, Xin, Zhong, Kunhong, Hu, Yating, Guo, Gang, Zhou, Liangxue, Guo, Wenhao, Xu, Jianguo, Yang, Hui, Tong, Aiping
Publicado 2020

Lipid Nanoparticle Delivery System for mRNA Encoding B7H3‐redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors

por Huang, Cheng, Duan, Xing, Wang, Jichao, Tian, Qingqing, Ren, Yangmei, Chen, Kepan, Zhang, Zongliang, Li, Yuanyou, Feng, Yunyu, Zhong, Kunhong, Wang, Yuelong, Zhou, Liangxue, Guo, Gang, Song, Xiangrong, Tong, Aiping
Publicado 2022

The suppressive functions of Rora in B lineage cell proliferation and BCR/ABL1-induced B-ALL pathogenesis

por Li, Ning, Wang, Nan, He, Wei, Feng, Yunyu, Qiu, Qiang, Qiu, Huandi, Zheng, Li, Yin, Yuexia, Wang, Bochuan, Sun, Yuanyuan, Pan, Cong, Sample, Klarke M., Huang, Juan, Su, Zhiguang, Li, Zhihui, Zhang, Haojian, Hu, Yiguo
Publicado 2022

HDAC I/IIb selective inhibitor Purinostat Mesylate combined with GLS1 inhibition effectively eliminates CML stem cells

por Qiu, Qiang, yang, Linyu, Feng, Yunyu, Zhu, Zejiang, Li, Ning, Zheng, Li, Sun, Yuanyuan, Pan, Cong, Qiu, Huandi, Cui, Xue, He, Wei, Wang, Fang, Yi, Yuyao, Tang, Minghai, Yang, Zhuang, Yang, Yunfan, Li, Zhihui, Chen, Lijuan, Hu, Yiguo
Publicado 2022

TSPAN32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing PTEN

por Qiu, Qiang, Sun, Yuanyuan, Yang, Linyu, Li, Qingqing, Feng, Yunyu, Li, Mengyuan, Yin, Yuexia, Zheng, Li, Li, Ning, Qiu, Huandi, Cui, Xue, He, Wei, Wang, Bochuan, Pan, Cong, Wang, Zi, Huang, Juan, Sample, Klarke M., Li, Zhihui, Hu, Yiguo
Publicado 2023

Combination therapy with B7H3-redirected bispecific antibody and Sorafenib elicits enhanced synergistic antitumor efficacy

por Huang, Cheng, Li, Hongjian, Feng, Yunyu, Li, Xiaoling, Zhang, Zongliang, Jiang, Caiying, Wang, Jichao, Yang, Chenli, Fu, Yuying, Mu, Min, Zhao, Shasha, Wang, Zeng, Kuang, Yi, Hou, Huan, Wang, Yuelong, Guo, Wenhao, Xu, Jianguo, Yang, Hui, Zhou, Liangxue, Tong, Aiping, Guo, Gang
Publicado 2020